If I Knew Then: Matthew H. J. Kim

If I Knew Then: Matthew H. J. Kim October 31, 2016 The Mistake: I fell in love with a technology before understanding the impact or value the technology can have in the real world. In my prior medical startup, I created a drug delivery platform which had a very novel way of delivering medication to

Save Lives With Simple Oral Cancer Screenings

Save Lives With Simple Oral Cancer Screenings October 17, 2016 According to the World Health Organization, there are more than 529,000 new cases of oral (lip, oral cavity, and pharynx) cancer each year worldwide, with mortality rates reaching up to 292,000 deaths each year.1 In the United States, more than 48,000 individuals will be diagnosed with

MoneyTree Report: Florida’s Venture Dollars on Track to Surpass 2015

MoneyTree Report: Florida’s Venture Dollars on Track to Surpass 2015 October 14, 2016 Florida’s startup and expanding companies so far this year have raised $1 billion in venture capital and angel investments, more than double 2015’s total of $459.89 million, according to a MoneyTree Report released Friday. While on track for the best year since

Vigilant Biosciences Awarded Grant for Oral Cancer Diagnostic System

Vigilant Biosciences Awarded Grant for Oral Cancer Diagnostic System October 12, 2016 Vigilant Biosciences, a developer of solutions that aid in the early detection and intervention of cancer, has received a Phase I Small Business Innovation Research grant of $219,454 from the National Institute of Dental and Craniofacial Research. The 15-month grant will fund research

Cell Biomarkers To Distinguish Deadly From Less Aggressive HPV Oral Cancers

Cell Biomarkers To Distinguish Deadly From Less Aggressive HPV Oral Cancers October 3, 2016 MedicalResearch.com interview with: Elizabeth Franzmann, M.D. Scientific Founder and Chief Scientific Officer Vigilant Biosciences MedicalResearch.com: What is the background for this study? Response: Head and neck cancer involves cancers of the oral cavity, oropharynx and larynx. It is difficult to treat.

© 2020 Vigilant Biosciences

Follow Us

3900001 Rev C